Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Bacteria or actinomycetales
Patent
1995-05-24
1996-12-03
Naff, David M.
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Bacteria or actinomycetales
435245, 4352521, 4352528, 435879, A01N 6300, C12N 136, C12N 120
Patent
active
055805574
ABSTRACT:
Disclosed herein are methods for attenuating virulent gram negative bacteria to produce avirulent bacteria. The methods comprise passaging the wild-type bacteria through phagocytic cells, such as macrophages or polymorphonuclear leukocytes, or through lysosomes derived from such cells, a sufficient number of times until the bacteria become avirulent to the animal host. The bacteria are preferably from the family Enterobacteracea and most preferably from the genus Salmonellae. The invention further comprises the avirulent bacteria produced by the methods, pure cultures of such bacteria, and methods of using the bacteria, preferably in a vaccine for administration to an animal host to induce an immune response to the wild-type gram negative bacteria in the host.
REFERENCES:
patent: 3907987 (1975-09-01), Wilson
patent: 3950512 (1976-04-01), Emery et al.
patent: 3975517 (1976-08-01), Wilson
patent: 4503036 (1985-03-01), Girardone et al.
patent: 4764370 (1988-08-01), Fields et al.
patent: 5436001 (1995-07-01), Kramer
Kramer et al., Am. J. Vet. Res., 53(4): 444-48 (1992).
Sluzewska et al., Pol. Arch. Weter, 18(2): 161-74 (1975).
Smith et al., J. Pathol. Bacteriol., 93: 141-56 (1967).
Lawson et al., Brit. Vet. J., 121: 521-31 (1965).
Scholl e tal., Arch. Exper. Vet. Med., 34: 91-97 (1980).
Turfano et al., Microbiol Pathogenesis, 7: 337-46 (1989).
Gulig, Microbial Pathogenesis, 8: 3-11 (1990).
Buchmeier et al., Infection and Immunity, 57: 1-7 (1989).
Fields et al., Science 243: 1059-62 (1989).
Buchmeier et al., Science 248: 730-32 (1990).
Griffith et al., Am. J. Vet. Res., 45: 1342-48 (1984).
Fields et al., Proc. Natl. Acad. Sci., 83: 5189-93 (1986).
Maurelli, Microbial Pathogenesis, 7: 1-10 (1989).
Groisman et al., PNAS, 86: 7077-81 (1989).
Finlay et al., J of NIH Res., 1: 84-87 (1989).
Dougan et al., Adv. Ve. Rad. Vet. Sci. and Comp. Med., 33: 271-300 (1989).
Roof et al., Vet. Immunology & Immunopathology, 23(3-4): 365-76 (1989).
Griffith et al., Vet. Immunology & Immunopathology,, 4: 593-601 (1983).
Mungar et al., Abstracts of the Annual Meeting, 1983, p. 92 (E98).
Kramer et al., Am. J. Vet. Res., 48(7): 1072-76 (1987).
Finlay et al., J. Cell. Biol., 107: 221-30 (1988).
Roof et al., Am. J. Vet. Res., 53: 1328-32 (1992).
Kramer et al., "Local and Systemic Immunity to Salmonella Choleraesuis", Proc. of the 91st Annual Meeting of the US animal Health Assn., Salt Lake City, Utah 1987.
Smith, J. Hyg. Camb., 63: 117-35 *1965).
Taira et al., Microbial Pathogenesis, 7: 165-73 (1989).
Benjamin et al., Infection & Immunity, 51: 872-78 (1986).
Nnalue et al.Infection & Immunity, 55: 955-62 (1987).
Nnalue, Med. Micrbiol., 31: 225-33 (1990).
Quaife, Swine Practitioner, pp. 4-7 (Feb. 1992).
Collins et al., Infect. Immun., 39(2): 779-84 (1983).
Horwitz, J. Exp. Med., 166(5): 1310-28 (1987).
Dadio Susan M.
Iowa State University & Research Foundation, Inc.
Naff David M.
LandOfFree
Live, avirulent salmonella choleraesuis vaccine used for inducin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Live, avirulent salmonella choleraesuis vaccine used for inducin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Live, avirulent salmonella choleraesuis vaccine used for inducin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-783272